首页|人凝血因子Ⅷ生产场地变更的质量可比性分析

人凝血因子Ⅷ生产场地变更的质量可比性分析

扫码查看
目的 对生产场地变更前后生产的人凝血因子Ⅷ(factor Ⅷ,FⅧ)开展质量可比性研究.方法 对生产场地变更前后生产的FⅧ定量质量指标、相关杂质和稳定性数据进行比较研究.结果 场地变更前后生产的FⅧ定量质量指标均符合标准要求,有关杂质包括铝残留量、磷酸三丁酯残留量、聚山梨酯80残留量、聚乙二醇(PEG)残留量均符合标准要求,其他杂质包括人纤维蛋白原、纤维结合蛋白、纤溶酶原、IgA、IgM、IgG含量均极低且质量相当,VWF(血管性血友病因子)在场地变更前后含量无明显变化,但明显高于国内其他厂家市售产品.加速稳定性和长期稳定性试验结果表明FⅧ效价在方法学误差范围内存在波动,结果均符合标准要求.结论 FⅧ生产场地变更未对其制品质量产生影响.
Quality comparability analysis on production site change of human coagulation factor Ⅷ
Objective To study the quality comparability of human coagulation factor Ⅷ(FⅧ)produced before and after the change of factory site.Methods A comparative study was carried out on quality quantitative indexes,related im-purities and stability data of FⅧ produced before and after the change of factory site.Results The FⅧ quantitative quality before and after the change of factory site all met the quality standard,and the related impurities including aluminum resi-due,tributyl phosphate residue,polysorbate 80 residue and PEG residue all met the quality standard.Other impurities in-cluding human fibrinogen,fibronectin,plasminogen,IgA,IgM and IgG were extremely low in content and equivalent in quality.The content of VWF(von Willebrand factor)had no obvious change before and after the change of factory site,but was significantly higher than that of other domestic manufacturers'commercial products.The results of accelerated stability and long-term stability tests showed that the titer of FⅧ fluctuated within the methodological error range,and the results all met the quality standard.Conclusion The change of factory site of FⅧ has no effect on the quality.

human coagulation factor Ⅷ(FⅧ)site changequality indexes

田天丽、王菡钰、马异云、薛魏、张胜潮、张耀尹、周顺波、邹玲玲、陈川、丁亚凌

展开 >

成都蓉生药业有限责任公司血浆检测部,四川成都 610000

成都蓉生药业有限责任公司质量保证部,四川成都 610000

成都蓉生药业有限责任公司科研质量部,四川成都 610000

FⅧ 生产场地变更 质量指标

2024

中国输血杂志
中国输血协会 中国医学科学院输血研究所

中国输血杂志

CSTPCD
影响因子:1.279
ISSN:1004-549X
年,卷(期):2024.37(10)